D

Design Therapeutics

66 employees

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Basic info

Industry

pharmaceutical manufacturing
biotechnology research

Sectors

Biotechnology
Medical
Life Science

Date founded

2017

Funding rounds raised

Total raised

$125M

from 12 investors over 12 rounds

D

Design Therapeutics raised $125M on January 27, 2021

Investors: Surveyor Capital, T. Rowe Price, Vivo Capital, Quan Capital 泉创资本, S.R. One Ltd, Wellington Management, Logos Global Management, LP, WestRiver Group and RA Capital Management, L.P.

D

Design Therapeutics raised $46M on March 20, 2020

Investors: Quan Capital 泉创资本, S.R. One Ltd and WestRiver Group

FAQ